Exhibiting at FOOD INGREDIENTS CHINA 2025

Hangzhou Xinfu Science & Technology Co., Ltd. (杭州鑫富科技有限公司) is a China-based biotechnology and pharmaceutical ingredient manufacturer headquartered in Hangzhou, Zhejiang Province. The company is recognized for its production of high-purity vitamins and active pharmaceutical ingredients (APIs), with a particular focus on derivatives of Vitamin B5 and innovative biomedical materials.

Brief History

Established in the industrial hub of Hangzhou, Xinfu Science & Technology has steadily evolved into a global supplier of pharmaceutical-grade raw materials. The company’s operational foundation is built upon strong R&D, quality control systems, and integration with international regulatory standards.

Core Business

Hangzhou Xinfu specializes in the production of vitamins and their derivatives, catering primarily to the pharmaceutical, cosmetics, and nutraceutical sectors. The company's key strength lies in its production of Vitamin B5-related products using high-standard fermentation and synthesis processes.

Product and Service Offerings

Xinfu's core product lines include:

• D-Calcium Pantothenate (Vitamin B5)

  • Used in multivitamin formulations, energy drinks, feed additives, and pharmaceuticals.
  • Complies with USP, EP, and FCC quality standards.

• D-Panthenol (Pro-vitamin B5)

  • Widely used in cosmetic and personal care products for its moisturizing and skin-healing properties.
  • Available in various purity grades for pharmaceutical and industrial use.

• RegeSi

  • A new generation of regenerative medical material based on bioactive silicon.
  • Targets tissue regeneration, orthopedic implants, and wound healing applications.

These products are manufactured in GMP-certified facilities and undergo rigorous quality testing.

Specialization and USP

The company’s core competencies include:

• High-purity Vitamin B5 Production using bio-fermentation
• Integrated Fermentation and Chemical Synthesis Lines
• Regenerative Biomaterials R&D under the brand name RegeSi
• Strong Regulatory Compliance for exports to the U.S., EU, and Japan

Xinfu’s unique advantage is its vertical integration and specialization in Vitamin B5 derivatives, positioning it as one of the few Chinese companies with global-scale supply capability in this niche.

Financials

While specific financials are not publicly disclosed, Hangzhou Xinfu is recognized as a key supplier in the global Vitamin B5 market. Its consistent exports and participation in global pharmaceutical ingredient trade fairs signal healthy financial operations and sustainable revenue streams.

Shipment Data

Based on data from international trade sources:

• Primary Export Markets: United States, Germany, India, Japan, Brazil
• Top Exported Products: D-Calcium Pantothenate, D-Panthenol
• Annual Export Volume: Estimated hundreds of metric tons based on trade activity
• Regular Buyers: Global pharmaceutical manufacturers, vitamin and supplement brands

Xinfu’s products are regularly listed in customs data and international sourcing platforms, indicating compliance with global regulatory standards.

Target Market

• Pharmaceutical manufacturers
• Nutraceutical and dietary supplement producers
• Personal care and cosmetic brands
• Biomedical and regenerative medicine firms
• Global ingredient distributors

Xinfu serves clients ranging from multinational pharmaceutical companies to regional cosmetic formulators.

Capabilities

• GMP-compliant manufacturing plants
• ISO-certified quality systems
• Independent R&D for biomedical innovation
• Automated fermentation and chemical synthesis lines
• In-house testing labs with HPLC, GC, and microbial analysis

Certifications and Compliance

• GMP (Good Manufacturing Practices)
• ISO 9001 Quality Management System
• Compliant with USP, EP, JP standards
• Likely holds export certifications for key markets (documentation available upon request)

These certifications enable Xinfu to export to highly regulated pharmaceutical markets globally.

Customer Testimonials

Although specific customer reviews are not publicly listed, repeated trade relationships with multinational clients and regular participation in international pharma exhibitions (e.g., CPhI Worldwide) affirm the company’s strong reputation.

Major Achievements

• Established as a leading supplier of D-Calcium Pantothenate in the global market
• Launched RegeSi, a proprietary regenerative silicon biomaterial, expanding into medical devices
• Maintains long-term supply agreements with global pharmaceutical and nutraceutical brands
• Successfully penetrated highly regulated markets such as the EU, U.S., and Japan with GMP-compliant APIs